160 related articles for article (PubMed ID: 7844608)
1. Randomized trial of hyperfractionated radiation therapy with or without concurrent chemotherapy for stage III non-small-cell lung cancer.
Jeremic B; Shibamoto Y; Acimovic L; Djuric L
J Clin Oncol; 1995 Feb; 13(2):452-8. PubMed ID: 7844608
[TBL] [Abstract][Full Text] [Related]
2. Hyperfractionated radiation therapy with or without concurrent low-dose daily carboplatin/etoposide for stage III non-small-cell lung cancer: a randomized study.
Jeremic B; Shibamoto Y; Acimovic L; Milisavljevic S
J Clin Oncol; 1996 Apr; 14(4):1065-70. PubMed ID: 8648358
[TBL] [Abstract][Full Text] [Related]
3. Hyperfractionated radiation therapy and concurrent low-dose, daily carboplatin/etoposide with or without weekend carboplatin/etoposide chemotherapy in stage III non-small-cell lung cancer: a randomized trial.
Jeremic B; Shibamoto Y; Acimovic L; Milicic B; Milisavljevic S; Nikolic N; Dagovic A; Aleksandrovic J; Radosavljevic-Asic G
Int J Radiat Oncol Biol Phys; 2001 May; 50(1):19-25. PubMed ID: 11316542
[TBL] [Abstract][Full Text] [Related]
4. From conventionally fractionated radiation therapy to hyperfractionated radiation therapy alone and with concurrent chemotherapy in patients with early-stage nonsmall cell lung cancer.
Jeremić B; Milicić B
Cancer; 2008 Feb; 112(4):876-84. PubMed ID: 18172901
[TBL] [Abstract][Full Text] [Related]
5. Impact of adding concurrent chemotherapy to hyperfractionated radiotherapy for locally advanced non-small cell lung cancer (NSCLC): comparison of RTOG 83-11 and RTOG 91-06.
Komaki R; Scott C; Lee JS; Urtasun RC; Byhardt RW; Emami B; Andras EJ; Asbell SO; Rotman M; Cox JD
Am J Clin Oncol; 1997 Oct; 20(5):435-40. PubMed ID: 9345325
[TBL] [Abstract][Full Text] [Related]
6. Pre-treatment prognostic factors in patients with stage III non-small cell lung cancer treated with hyperfractionated radiation therapy with or without concurrent chemotherapy.
Jeremic B; Shibamoto Y
Lung Cancer; 1995 Aug; 13(1):21-30. PubMed ID: 8528637
[TBL] [Abstract][Full Text] [Related]
7. Hyperfractionated radiation therapy with and without concurrent chemotherapy for advanced non-small cell lung cancer.
Jeremic B; Jevremovic S; Mijatovic L; Milisavljevic S
Cancer; 1993 Jun; 71(11):3732-6. PubMed ID: 8387885
[TBL] [Abstract][Full Text] [Related]
8. Concurrent hyperfractionated radiotherapy and low-dose daily carboplatin and paclitaxel in patients with stage III non-small-cell lung cancer: long-term results of a phase II study.
Jeremic B; Milicic B; Acimovic L; Milisavljevic S
J Clin Oncol; 2005 Feb; 23(6):1144-51. PubMed ID: 15718310
[TBL] [Abstract][Full Text] [Related]
9. Response, toxicity, failure patterns, and survival in five Radiation Therapy Oncology Group (RTOG) trials of sequential and/or concurrent chemotherapy and radiotherapy for locally advanced non-small-cell carcinoma of the lung.
Byhardt RW; Scott C; Sause WT; Emami B; Komaki R; Fisher B; Lee JS; Lawton C
Int J Radiat Oncol Biol Phys; 1998 Oct; 42(3):469-78. PubMed ID: 9806503
[TBL] [Abstract][Full Text] [Related]
10. Stage III non-small-cell lung cancer treated with high-dose hyperfractionated radiation therapy and concurrent low-dose daily chemotherapy with or without weekend chemotherapy: retrospective analysis of 301 patients.
Jeremic B; Milicic B; Dagovic A; Aleksandrovic J; Milisavljevic S
Am J Clin Oncol; 2004 Aug; 27(4):350-60. PubMed ID: 15289727
[TBL] [Abstract][Full Text] [Related]
11. Concurrent hyperfractionated radiotherapy and low-dose daily carboplatin/paclitaxel in patients with early-stage (I/II) non-small-cell lung cancer: long-term results of a phase II study.
Jeremić B; Milicić B; Acimović L; Milisavljević S
J Clin Oncol; 2005 Oct; 23(28):6873-80. PubMed ID: 16192579
[TBL] [Abstract][Full Text] [Related]
12. Initial versus delayed accelerated hyperfractionated radiation therapy and concurrent chemotherapy in limited small-cell lung cancer: a randomized study.
Jeremic B; Shibamoto Y; Acimovic L; Milisavljevic S
J Clin Oncol; 1997 Mar; 15(3):893-900. PubMed ID: 9060525
[TBL] [Abstract][Full Text] [Related]
13. Effect of interfraction interval in hyperfractionated radiotherapy with or without concurrent chemotherapy for stage III nonsmall cell lung cancer.
Jeremic B; Shibamoto Y
Int J Radiat Oncol Biol Phys; 1996 Jan; 34(2):303-8. PubMed ID: 8567330
[TBL] [Abstract][Full Text] [Related]
14. Radiation therapy with or without concurrent low-dose daily chemotherapy in locally advanced, nonmetastatic squamous cell carcinoma of the head and neck.
Jeremic B; Milicic B; Dagovic A; Vaskovic Z; Tadic L
J Clin Oncol; 2004 Sep; 22(17):3540-8. PubMed ID: 15337803
[TBL] [Abstract][Full Text] [Related]
15. Role of radiation therapy in the combined-modality treatment of patients with extensive disease small-cell lung cancer: A randomized study.
Jeremic B; Shibamoto Y; Nikolic N; Milicic B; Milisavljevic S; Dagovic A; Aleksandrovic J; Radosavljevic-Asic G
J Clin Oncol; 1999 Jul; 17(7):2092-9. PubMed ID: 10561263
[TBL] [Abstract][Full Text] [Related]
16. Induction cisplatin/vinblastine and irradiation vs. irradiation in unresectable squamous cell lung cancer: failure patterns by cell type in RTOG 88-08/ECOG 4588. Radiation Therapy Oncology Group. Eastern Cooperative Oncology Group.
Komaki R; Scott CB; Sause WT; Johnson DH; Taylor SG; Lee JS; Emami B; Byhardt RW; Curran WJ; Dar AR; Cox JD
Int J Radiat Oncol Biol Phys; 1997 Oct; 39(3):537-44. PubMed ID: 9336129
[TBL] [Abstract][Full Text] [Related]
17. Interfraction interval in patients with stage III non-small-cell lung cancer treated with hyperfractionated radiation therapy with or without concurrent chemotherapy: final results in 536 patients.
Jeremic B; Milicic B; Dagovic A; Aleksandrovic J; Milisavljevic S
Am J Clin Oncol; 2004 Dec; 27(6):616-25. PubMed ID: 15577441
[TBL] [Abstract][Full Text] [Related]
18. Radiotherapy and chemotherapy in locally advanced non-small cell lung cancer: preclinical and early clinical data.
Reboul FL
Hematol Oncol Clin North Am; 2004 Feb; 18(1):41-53. PubMed ID: 15005280
[TBL] [Abstract][Full Text] [Related]
19. A phase II study of concurrent accelerated hyperfractionated radiotherapy and carboplatin/oral etoposide for elderly patients with stage III non-small-cell lung cancer.
Jeremic B; Shibamoto Y; Milicic B; Milisavljevic S; Nikolic N; Dagovic A; Aleksandrovic J; Radosavljevic-Asic G
Int J Radiat Oncol Biol Phys; 1999 May; 44(2):343-8. PubMed ID: 10760429
[TBL] [Abstract][Full Text] [Related]
20. Alternating radiotherapy and chemotherapy for inoperable Stage III non-small-cell lung cancer: long-term results of two Phase II GOTHA trials. Groupe d'Oncologie Thoracique Alpine.
Mirimanoff RO; Moro D; Bolla M; Michel G; Brambilla C; Mermillod B; Miralbell R; Alberto P
Int J Radiat Oncol Biol Phys; 1998 Oct; 42(3):487-94. PubMed ID: 9806505
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
